Toceranib (SU11654) is an Orally Active RTK Inhibitor

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. In addition, RTKs are not only critical regulators of normal cellular processes,…